An Ecosystems Approach to Solving the Healthcare Puzzle Hosted by Cure®

Despite progress in breakthroughs and therapies, much remains to be done to fix our fragmented global healthcare system. The COVID-19 pandemic showcased biomedicine at its best with the rapid development of vaccines but also revealed a system riddled with inefficiencies, inequalities, and other barriers—and a rising distrust of science—that threaten to hamper further progress towards healthier outcomes for all.

Join us in this timely conversation and fun “building” activity as a starting point to solve the healthcare puzzle via greater cooperation and positive change in our fragmented world. This intimate event will convene forward-looking leaders from across disciplines and sectors to discuss how it will take not just a village, but entire new ecosystems to solve the critical health challenges of tomorrow and beyond.

Light reception to follow.

If you have any questions, please contact:

CureatDavos@apcoworldwide.com

Confirmed Speakers

Seema Kumar

CEO, Cure

Ms. Kumar joins Cure from Johnson & Johnson where she spent nearly 20 years in senior leadership positions, most recently serving as Global Head of the Office of Innovation, Global Health and Scientific Engagement. During her tenure, she led the launch of the company’s Innovation Centers, JLABS and Global Public Health initiatives, as well as the CoLaboratory at the World Economic Forum at Davos and the award winning COVID-19 educational broadcast program, “The Road to a Vaccine.”

Rick A. Bright, Ph.D.

Former Chief Executive Officer

Rick Bright is formerly the Chief Executive Officer of the Pandemic Prevention Institute (PPI) at The Rockefeller Foundation. Dr. Bright lead the development of the Foundation’s pandemic data-to-action platform that integrates modern technology, data analytics and global partners to help the world detect, prevent, and mitigate pandemic threats to achieve containment as quickly as possible.

Francis deSouza

CEO, Illumina

Francis deSouza was appointed CEO of Illumina in 2016 and is responsible for directing all aspects of company strategy, planning, and operations. He initially joined the company as President in 2013 and led Illumina’s business units and core functions responsible for envisioning, developing, and producing the company’s products.

Beth Thompson MBE

Director of Strategy, Wellcome

Beth joined Wellcome in 2009. She became interim Director of Strategy in 2022, responsible for the work of the strategy and programme office, government relations and strategic partnerships, policy, and transition and legacy teams.

Katja Iversen

Executive Adviser, Author, and Advocate

Katja Iversen is an executive adviser, author, board member and global advocate on sustainability, purpose driven leadership, global health and gender equality. She is a sought keynote speaker and moderator, and she holds various board and executive advisory roles, including with the World Economic Forum, Women Political Leaders, 4LifeSolutions, Kings College Institute for Women’s Leadership, Goal Goals World Cup and Global Health 50/50. She also sits on UNILEVER’s Global Sustainability Advisory Council and has been appointed a UN Food Champion and Copenhagen Goodwill Ambassador.

Victor J. Dzau, M.D.

President, US National Academy of Medicine (NAM)

Victor J. Dzau, M.D. is the President of the US National Academy of Medicine (NAM), Vice Chair of the US National Research Council, and is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University. Dr. Dzau was previously Hersey Professor of Medicine at Harvard Medical School and Chairman of Department of Medicine at Brigham and Women’s Hospital as well as Bloomfield Professor and Chairman of Department of Medicine at Stanford, as well as William Irwin Professor and Chief of the Cardiovascular Division and Director of Cardiovascular Research Center at Stanford.

Daniella Foster

Executive Board Member & SVP Public Affairs, Science and Sustainability, Consumer Health, Bayer

Daniella Foster is the Executive Board Member & SVP Public Affairs, Science and Sustainability for Bayer. Previously, she was Senior Director of Global Corporate Responsibility at Hilton, where she leads global strategy, youth economic opportunity, social and environmental investments, signature partnerships and reporting across Hilton’s value chain. A policy innovator and social entrepreneur, she co-founded the Emergent Leaders Network and has spent her career focused on actionable innovation in the government, business and non-profit sectors.